Jeffrey Alexander
Internal Medicine · Towson, MDNPI 1659479178
Payments from drug & device makers
Across 124 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$740
- AbbVie$394
- Novo Nordisk$335
- GSK$259
- Boehringer Ingelheim$236
- Sanofi-aventis U.S. LLC$120
- plus $499 from 13 others
What the payments were for
- Food & beverage$2,48096%
- Education$1024%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $740 |
| AbbVie(2 entities) | 24 | $394 |
| Novo Nordisk | 20 | $335 |
| GSK | 10 | $259 |
| Boehringer Ingelheim | 15 | $236 |
| Sanofi-aventis U.S. LLC | 1 | $120 |
| Astellas Pharma US Inc | 2 | $111 |
| Lilly USA, LLC | 6 | $92 |
| Pfizer | 4 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Novartis | 3 | $43 |
| Exact Sciences | 2 | $31 |
| Genentech USA, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Abbott | 1 | $14 |
| Merck | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$123
- PRALUENT$120
- FARXIGA$111
- AIRSUPRA$109
How this compares
$2,582 in reported general payments places this provider in the 80th percentile of 2,979 internal medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 167 | $211,633 |
| OzempicSemaglutide | 87 | $110,762 |
| MounjaroTirzepatide | 73 | $77,675 |
| FarxigaDapagliflozin Propanediol | 35 | $52,435 |
| TrulicityDulaglutide | 29 | $46,775 |
| EntrestoSacubitril/Valsartan | 29 | $37,520 |
| JardianceEmpagliflozin | 31 | $36,412 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $32,906 |
| MyrbetriqMirabegron | 24 | $29,781 |
| XareltoRivaroxaban | 26 | $23,937 |
| Repatha SureclickEvolocumab | 19 | $18,367 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $13,942 |
| Rosuvastatin Calcium | 285 | $5,219 |
| Ezetimibe | 80 | $4,309 |
| PaxlovidNirmatrelvir/Ritonavir | 23 | $4,288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $61 | $215,920190 claims |
| Lilly USA, LLCMounjaro, Trulicity, Olanzapine | $92 | $125,717113 claims |
| Novo NordiskOzempic | $335 | $110,76287 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $740 | $66,37756 claims |
| NovartisEntresto | $43 | $37,52029 claims |
| Boehringer IngelheimJardiance | $236 | $36,41231 claims |
| GSKTrelegy Ellipta | $259 | $32,90625 claims |
| Astellas Pharma US IncMyrbetriq | $111 | $29,78124 claims |
| AbbVieSynthroid | $394 | $2,27338 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Towson
- Gregory PokrywkaTowson$410K
- Shishir KhetanRockville$52.1M
- Steven GellerElkridge$15.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
- Rahul PatelRockville$2.8M
- Mark YarchoanBaltimore$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.